フィルグラスチム注射のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Filgrastim Injection Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16167 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

フィルグラスチム注射市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のフィルグラスチム注射の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のフィルグラスチム注射の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 フィルグラスチム注射市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・300mcg/mL（バイアル）、480mcg/1.6mL（バイアル）、300mcg/0.5mL（プレフィルドシリンジ）、480mcg/0.8mL（プレフィルドシリンジ） 用途別セグメントは次のように区分されます。 ・成人用、小児用、高齢者用 世界のフィルグラスチム注射市場の主要な市場プレーヤーは以下のとおりです。 ・Accord Healthcare、Teva Pharmaceuticals、Pfizer、Amgen Inc、Novartis AG 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、フィルグラスチム注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なフィルグラスチム注射メーカーの企業概要、2019年～2021年までのフィルグラスチム注射の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なフィルグラスチム注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別フィルグラスチム注射の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのフィルグラスチム注射の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのフィルグラスチム注射市場予測を収録しています。 ・第12、13、14章では、フィルグラスチム注射の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Accord Healthcare、Teva Pharmaceuticals、Pfizer、Amgen Inc、Novartis AG ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：300mcg/mL（バイアル）、480mcg/1.6mL（バイアル）、300mcg/0.5mL（プレフィルドシリンジ）、480mcg/0.8mL（プレフィルドシリンジ） ・用途別分析2016年-2026年：成人用、小児用、高齢者用 ・フィルグラスチム注射の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・フィルグラスチム注射のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・フィルグラスチム注射のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・フィルグラスチム注射の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・フィルグラスチム注射の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Filgrastim Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Filgrastim Injection size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Filgrastim Injection market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Filgrastim Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
300mcg/mL (vial)
480mcg/1.6 mL (vial)
300mcg/0.5mL (Prefilled Syringe)
480mcg/0.8mL (Prefilled Syringe)

Market segment by Application can be divided into
Adult Use
Pediatric Use
Geriatric Use

The key market players for global Filgrastim Injection market are listed below:
Accord Healthcare
Teva Pharmaceuticals
Pfizer
Amgen Inc
Novartis AG

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Filgrastim Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Filgrastim Injection, with price, sales, revenue and global market share of Filgrastim Injection from 2019 to 2021.
Chapter 3, the Filgrastim Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Filgrastim Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Filgrastim Injection market forecast, by regions, dosage form & strength type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Filgrastim Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Filgrastim Injection Introduction
1.2 Market Analysis by Dosage Form & Strength Type
1.2.1 Overview: Global Filgrastim Injection Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 300mcg/mL (vial)
1.2.3 480mcg/1.6 mL (vial)
1.2.4 300mcg/0.5mL (Prefilled Syringe)
1.2.5 480mcg/0.8mL (Prefilled Syringe)
1.3 Market Analysis by Application
1.3.1 Overview: Global Filgrastim Injection Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adult Use
1.3.3 Pediatric Use
1.3.4 Geriatric Use
1.4 Global Filgrastim Injection Market Size & Forecast
1.4.1 Global Filgrastim Injection Sales in Value (2016-2026))
1.4.2 Global Filgrastim Injection Sales in Volume (2016-2026)
1.4.3 Global Filgrastim Injection Price by Type (2016-2026) & (US$/L)
1.5 Global Filgrastim Injection Production Capacity Analysis
1.5.1 Global Filgrastim Injection Total Production Capacity (2016-2026)
1.5.2 Global Filgrastim Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Filgrastim Injection Market Drivers
1.6.2 Filgrastim Injection Market Restraints
1.6.3 Filgrastim Injection Trends Analysis
2 Manufacturers Profiles
2.1 Accord Healthcare
2.1.1 Accord Healthcare Details
2.1.2 Accord Healthcare Major Business
2.1.3 Accord Healthcare Filgrastim Injection Product and Services
2.1.4 Accord Healthcare Filgrastim Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Teva Pharmaceuticals
2.2.1 Teva Pharmaceuticals Details
2.2.2 Teva Pharmaceuticals Major Business
2.2.3 Teva Pharmaceuticals Filgrastim Injection Product and Services
2.2.4 Teva Pharmaceuticals Filgrastim Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Filgrastim Injection Product and Services
2.3.4 Pfizer Filgrastim Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Amgen Inc
2.4.1 Amgen Inc Details
2.4.2 Amgen Inc Major Business
2.4.3 Amgen Inc Filgrastim Injection Product and Services
2.4.4 Amgen Inc Filgrastim Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Filgrastim Injection Product and Services
2.5.4 Novartis AG Filgrastim Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Filgrastim Injection Sales by Manufacturer
3.1 Global Filgrastim Injection Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Filgrastim Injection Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Filgrastim Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Filgrastim Injection Manufacturer Market Share
3.4.2 Top 6 Filgrastim Injection Manufacturer Market Share
3.5 Global Filgrastim Injection Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Filgrastim Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Filgrastim Injection Market Size by Region
4.1.1 Global Filgrastim Injection Sales in Volume by Region (2016-2026)
4.1.2 Global Filgrastim Injection Revenue by Region (2016-2026)
4.2 North America Filgrastim Injection Revenue (2016-2026)
4.3 Europe Filgrastim Injection Revenue (2016-2026)
4.4 Asia-Pacific Filgrastim Injection Revenue (2016-2026)
4.5 South America Filgrastim Injection Revenue (2016-2026)
4.6 Middle East and Africa Filgrastim Injection Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Filgrastim Injection Sales in Volume by Type (2016-2026)
5.2 Global Filgrastim Injection Revenue by Type (2016-2026)
5.3 Global Filgrastim Injection Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Filgrastim Injection Sales in Volume by Application (2016-2026)
6.2 Global Filgrastim Injection Revenue by Application (2016-2026)
6.3 Global Filgrastim Injection Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Filgrastim Injection Sales by Type (2016-2026)
7.2 North America Filgrastim Injection Sales by Application (2016-2026)
7.3 North America Filgrastim Injection Market Size by Country
7.3.1 North America Filgrastim Injection Sales in Volume by Country (2016-2026)
7.3.2 North America Filgrastim Injection Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Filgrastim Injection Sales by Type (2016-2026)
8.2 Europe Filgrastim Injection Sales by Application (2016-2026)
8.3 Europe Filgrastim Injection Market Size by Country
8.3.1 Europe Filgrastim Injection Sales in Volume by Country (2016-2026)
8.3.2 Europe Filgrastim Injection Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Filgrastim Injection Sales by Type (2016-2026)
9.2 Asia-Pacific Filgrastim Injection Sales by Application (2016-2026)
9.3 Asia-Pacific Filgrastim Injection Market Size by Region
9.3.1 Asia-Pacific Filgrastim Injection Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Filgrastim Injection Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Filgrastim Injection Sales by Type (2016-2026)
10.2 South America Filgrastim Injection Sales by Application (2016-2026)
10.3 South America Filgrastim Injection Market Size by Country
10.3.1 South America Filgrastim Injection Sales in Volume by Country (2016-2026)
10.3.2 South America Filgrastim Injection Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Filgrastim Injection Sales by Type (2016-2026)
11.2 Middle East & Africa Filgrastim Injection Sales by Application (2016-2026)
11.3 Middle East & Africa Filgrastim Injection Market Size by Country
11.3.1 Middle East & Africa Filgrastim Injection Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Filgrastim Injection Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Filgrastim Injection Typical Distributors
12.3 Filgrastim Injection Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Filgrastim Injection Revenue by Type, (USD Million), 2021-2026
Table 2. Global Filgrastim Injection Revenue by Application, (USD Million), 2021-2026
Table 3. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. Accord Healthcare Major Business
Table 5. Accord Healthcare Filgrastim Injection Product and Services
Table 6. Accord Healthcare Filgrastim Injection Sales (KL), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Teva Pharmaceuticals Major Business
Table 9. Teva Pharmaceuticals Filgrastim Injection Product and Services
Table 10. Teva Pharmaceuticals Filgrastim Injection Sales (KL), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Filgrastim Injection Product and Services
Table 14. Pfizer Filgrastim Injection Sales (KL), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 16. Amgen Inc Major Business
Table 17. Amgen Inc Filgrastim Injection Product and Services
Table 18. Amgen Inc Filgrastim Injection Sales (KL), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 20. Novartis AG Major Business
Table 21. Novartis AG Filgrastim Injection Product and Services
Table 22. Novartis AG Filgrastim Injection Sales (KL), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Filgrastim Injection Sales by Manufacturer (2019-2021e) & (KL)
Table 24. Global Filgrastim Injection Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Filgrastim Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Filgrastim Injection Production Capacity by Company, (KL): 2020 VS 2021
Table 27. Head Office and Filgrastim Injection Production Site of Key Manufacturer
Table 28. Filgrastim Injection New Entrant and Capacity Expansion Plans
Table 29. Filgrastim Injection Mergers & Acquisitions in the Past Five Years
Table 30. Global Filgrastim Injection Sales by Region (2016-2021e) & (KL)
Table 31. Global Filgrastim Injection Sales by Region (2021-2026) & (KL)
Table 32. Global Filgrastim Injection Revenue by Region (2016-2021e) & (USD Million)
Table 33. Global Filgrastim Injection Revenue by Region (2021-2026) & (USD Million)
Table 34. Global Filgrastim Injection Sales by Type (2016-2021e) & (KL)
Table 35. Global Filgrastim Injection Sales by Type (2021-2026) & (KL)
Table 36. Global Filgrastim Injection Revenue by Type (2016-2021e) & (USD Million)
Table 37. Global Filgrastim Injection Revenue by Type (2021-2026) & (USD Million)
Table 38. Global Filgrastim Injection Price by Type (2016-2021e) & (US$/L)
Table 39. Global Filgrastim Injection Price by Type (2021-2026) & (US$/L)
Table 40. Global Filgrastim Injection Sales by Application (2016-2021e) & (KL)
Table 41. Global Filgrastim Injection Sales by Application (2021-2026) & (KL)
Table 42. Global Filgrastim Injection Revenue by Application (2016-2021e) & (USD Million)
Table 43. Global Filgrastim Injection Revenue by Application (2021-2026) & (USD Million)
Table 44. Global Filgrastim Injection Price by Application (2016-2021e) & (US$/L)
Table 45. Global Filgrastim Injection Price by Application (2021-2026) & (US$/L)
Table 46. North America Filgrastim Injection Sales by Country (2016-2021e) & (KL)
Table 47. North America Filgrastim Injection Sales by Country (2021-2026) & (KL)
Table 48. North America Filgrastim Injection Revenue by Country (2016-2021e) & (USD Million)
Table 49. North America Filgrastim Injection Revenue by Country (2021-2026) & (USD Million)
Table 50. North America Filgrastim Injection Sales by Type (2016-2021e) & (KL)
Table 51. North America Filgrastim Injection Sales by Type (2021-2026) & (KL)
Table 52. North America Filgrastim Injection Sales by Application (2016-2021e) & (KL)
Table 53. North America Filgrastim Injection Sales by Application (2021-2026) & (KL)
Table 54. Europe Filgrastim Injection Sales by Country (2016-2021e) & (KL)
Table 55. Europe Filgrastim Injection Sales by Country (2021-2026) & (KL)
Table 56. Europe Filgrastim Injection Revenue by Country (2016-2021e) & (USD Million)
Table 57. Europe Filgrastim Injection Revenue by Country (2021-2026) & (USD Million)
Table 58. Europe Filgrastim Injection Sales by Type (2016-2021e) & (KL)
Table 59. Europe Filgrastim Injection Sales by Type (2021-2026) & (KL)
Table 60. Europe Filgrastim Injection Sales by Application (2016-2021e) & (KL)
Table 61. Europe Filgrastim Injection Sales by Application (2021-2026) & (KL)
Table 62. Asia-Pacific Filgrastim Injection Sales by Region (2016-2021e) & (KL)
Table 63. Asia-Pacific Filgrastim Injection Sales by Region (2021-2026) & (KL)
Table 64. Asia-Pacific Filgrastim Injection Revenue by Region (2016-2021e) & (USD Million)
Table 65. Asia-Pacific Filgrastim Injection Revenue by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific Filgrastim Injection Sales by Type (2016-2021e) & (KL)
Table 67. Asia-Pacific Filgrastim Injection Sales by Type (2021-2026) & (KL)
Table 68. Asia-Pacific Filgrastim Injection Sales by Application (2016-2021e) & (KL)
Table 69. Asia-Pacific Filgrastim Injection Sales by Application (2021-2026) & (KL)
Table 70. South America Filgrastim Injection Sales by Country (2016-2021e) & (KL)
Table 71. South America Filgrastim Injection Sales by Country (2021-2026) & (KL)
Table 72. South America Filgrastim Injection Revenue by Country (2016-2021e) & (USD Million)
Table 73. South America Filgrastim Injection Revenue by Country (2021-2026) & (USD Million)
Table 74. South America Filgrastim Injection Sales by Type (2016-2021e) & (KL)
Table 75. South America Filgrastim Injection Sales by Type (2021-2026) & (KL)
Table 76. South America Filgrastim Injection Sales by Application (2016-2021e) & (KL)
Table 77. South America Filgrastim Injection Sales by Application (2021-2026) & (KL)
Table 78. Middle East & Africa Filgrastim Injection Sales by Country (2016-2021e) & (KL)
Table 79. Middle East & Africa Filgrastim Injection Sales by Country (2021-2026) & (KL)
Table 80. Middle East & Africa Filgrastim Injection Revenue by Country (2016-2021e) & (USD Million)
Table 81. Middle East & Africa Filgrastim Injection Revenue by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa Filgrastim Injection Sales by Type (2016-2021e) & (KL)
Table 83. Middle East & Africa Filgrastim Injection Sales by Type (2021-2026) & (KL)
Table 84. Middle East & Africa Filgrastim Injection Sales by Application (2016-2021e) & (KL)
Table 85. Middle East & Africa Filgrastim Injection Sales by Application (2021-2026) & (KL)
Table 86. Direct Channel Pros & Cons
Table 87. Indirect Channel Pros & Cons
Table 88. Filgrastim Injection Typical Distributors
Table 89. Filgrastim Injection Typical Customers
List of Figures
Figure 1. Filgrastim Injection Picture
Figure 2. Global Filgrastim Injection Sales Market Share by Type in 2020
Figure 3. 300mcg/mL (vial)
Figure 4. 480mcg/1.6 mL (vial)
Figure 5. 300mcg/0.5mL (Prefilled Syringe)
Figure 6. 480mcg/0.8mL (Prefilled Syringe)
Figure 7. Global Filgrastim Injection Sales Market Share by Application in 2020
Figure 8. Adult Use
Figure 9. Pediatric Use
Figure 10. Geriatric Use
Figure 11. Global Filgrastim Injection Market Size, (USD Million) & (KL): 2020 VS 2021 VS 2026
Figure 12. Global Filgrastim Injection Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Filgrastim Injection Sales (2016-2026) & (KL)
Figure 14. Global Filgrastim Injection Price by Type (2016-2026) & (US$/L)
Figure 15. Global Filgrastim Injection Production Capacity (2016-2026) & (KL)
Figure 16. Global Filgrastim Injection Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Filgrastim Injection Market Drivers
Figure 18. Filgrastim Injection Market Restraints
Figure 19. Filgrastim Injection Market Trends
Figure 20. Global Filgrastim Injection Sales Market Share by Manufacturer in 2020
Figure 21. Global Filgrastim Injection Revenue Market Share by Manufacturer in 2020
Figure 22. Filgrastim Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Filgrastim Injection Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Filgrastim Injection Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Filgrastim Injection Sales Market Share by Region (2016-2026)
Figure 26. Global Filgrastim Injection Revenue Market Share by Region (2016-2026)
Figure 27. North America Filgrastim Injection Revenue (2016-2026) & (USD Million)
Figure 28. Europe Filgrastim Injection Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Filgrastim Injection Revenue (2016-2026) & (USD Million)
Figure 30. South America Filgrastim Injection Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Filgrastim Injection Revenue (2016-2026) & (USD Million)
Figure 32. Global Filgrastim Injection Sales Market Share by Type (2016-2026)
Figure 33. Global Filgrastim Injection Revenue Market Share by Type (2016-2026)
Figure 34. Global Filgrastim Injection Price by Type (2016-2026) & (US$/L)
Figure 35. Global Filgrastim Injection Sales Market Share by Application (2016-2026)
Figure 36. Global Filgrastim Injection Revenue Market Share by Application (2016-2026)
Figure 37. Global Filgrastim Injection Price by Application (2016-2026) & (US$/L)
Figure 38. North America Filgrastim Injection Sales Market Share by Type (2016-2026)
Figure 39. North America Filgrastim Injection Sales Market Share by Application (2016-2026)
Figure 40. North America Filgrastim Injection Sales Market Share by Country (2016-2026)
Figure 41. North America Filgrastim Injection Revenue Market Share by Country (2016-2026)
Figure 42. United States Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Filgrastim Injection Sales Market Share by Type (2016-2026)
Figure 46. Europe Filgrastim Injection Sales Market Share by Application (2016-2026)
Figure 47. Europe Filgrastim Injection Sales Market Share by Country (2016-2026)
Figure 48. Europe Filgrastim Injection Revenue Market Share by Country (2016-2026)
Figure 49. Germany Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Filgrastim Injection Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Filgrastim Injection Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Filgrastim Injection Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Filgrastim Injection Revenue Market Share by Region (2016-2026)
Figure 58. China Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Filgrastim Injection Sales Market Share by Type (2016-2026)
Figure 65. South America Filgrastim Injection Sales Market Share by Application (2016-2026)
Figure 66. South America Filgrastim Injection Sales Market Share by Country (2016-2026)
Figure 67. South America Filgrastim Injection Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Filgrastim Injection Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Filgrastim Injection Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Filgrastim Injection Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Filgrastim Injection Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Filgrastim Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

---